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doi:10.1016/j.jmii.2011.01.036Background: Human bocavirus (HBoV), first described in September 2005, was considered
a causative agent of previously unexplained respiratory tract diseases. However, only few
reports provide the evidence for an association between HBoV and respiratory tract diseases.
We conducted a prospective clinical and molecular study of HBoV in Taiwan.
Methods: We enrolled 705 children who visited our outpatient pediatric clinics in a medical
center because of symptoms and signs of respiratory tract infections from November 2008 to
October 2009. Throat swab was performed and HBoV polymerase chain reaction and viral
culture were done simultaneously.
Results: Positive viral results were confirmed in 159 (22.6%) of the 705 children. HBoV was
found in 35 samples and it was supposed to be as a single virus in 32 samples because
viral isolation of these 32 samples did not identify other virus. The other three patients
had coinfection with another virus. One child got HBoV reinfection 6 months after the first
infection. Seventy-one percentage of these HBoV infections occurred between November
and March. Of the 34 children with positive HBoV, 26 (76%) patients were younger than
5 years; their common symptoms were cough, rhinorrhea, and fever; the most common
diagnoses were bronchitis (34%, 12/35) and sinusitis (31%, 11/35) followed by pharyngitis
(29%, 10/35) and asthma exacerbation (26%, 9/35). Three of the 34 patients needed
hospitalization.of Pediatrics, National Taiwan University Hospital, College of Medicine, No. 8, Chung-Shan South Rd,
tw (L.-Y. Chang).
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324 C.-Y. Chuang et al.Conclusion: HBoV is an emerging human parvovirus that may cause respiratory tract infec-
tion in young children. Diseases associated with HBoV may range from pharyngitis, sinus-
itis, acute otitis media to bronchitis, asthma, and even pneumonia.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Human bocavirus (HBoV) was discovered by Allander et al.1
in 2005. It is a novel member in the genus parvovirus, family
Parvoviridae, and was identified in respiratory samples
from infants in Sweden using a random amplification and
cloning system. Afterward, HBoV was found worldwide
including Australia, North America, Europe, Asia, and
Africa,2e14 and it is not only isolated from the respiratory
tract, but also from the gastrointestinal tract.15e18 By
a specific polymerase chain reaction (PCR) assay, the virus
was found to be present in 17 (3.1%) of 540 respiratory
specimens collected from hospitalized children more than
a 1-year period.1 Among previous studies, HBoV was
detected in 1.5%e18.3% of respiratory samples from indi-
viduals with acute respiratory tract illness, especially those
from young children and infants.
The relative importance of HBoV as a causative pathogen
for viral respiratory illnesses has not been determined yet,
but it has been associated with respiratory diseases ranging
from upper respiratory tract disease to bronchiolitis,
and lower respiratory tract diseases, such as pneumo-
nia.3,10,19e21 So far it was controversially discussed whether
HBoV is indeed a pathogen rather than an innocent
bystander as it is frequently associated with coinfections
and Koch’s modified postulates cannot been fulfilled.22
Although HBoV had been found in patients of all ages,
most reports have suggested that children and infants are
the most at risk for infection by HBoV. Currently, the
methods of detecting HBoV include conventional
PCR1,2,4,5,12,23,24 and real-time PCR5,9,25e28 because of the
limited success of serological and viral culture techniques.
To better understand the causative pathogen of respiratory
tract infections of children in clinical practice and the
relevance with the clinical presentations, we performed
a prospective study of examining the specimens from
pediatric patients with respiratory tract infections in
Taiwanese children.
Methods
Patients and samples
From November 2008 to October 2009, 705 samples were
collected from children aged between 5 months and 9
years, who were diagnosed with an acute respiratory tract
infection. All specimens were collected at the Taiwan
University Children Hospital, with informed consent from
the children’s parents. Two throat swab samples were
collected from each patient and stored in a viral transport
medium, and transported to a virology laboratory within 24
hours. The doctor who was involved in the study and per-
formed the sampling remained the same throughout thestudy. Furthermore, PCR of HBoV and viral culture were
done simultaneously.
Extraction of the virus genome DNA and PCR
Viral nucleic acids were extracted by using a QIAamp DNA
Blood Mini Kit (QIAGEN, Hilden, Germany) according to the
manufacturer’s instructions. HBoV was detected by PCR
using primers specific for two different regions of the
genome. The screening primers: 188F (2281-GACCTCTGTAA
GTACTATTAC-2301) and 542R (2634-CTCTGTGTTGACTGAAT
ACAG-2614)were described previously by Allander et al.1 and
amplified a 354-bp fragment of the putative NP-1 gene.1,29
HBoV DNA in the samples was confirmed and sequenced by
using some newly designed PCR with the following primers:
HBoV-Boca1F:50-GCCGGCAGACATATTGGATTCC-30, HBoV-
1139F:50-CGTCTTCTGTTAGCACTAC-30, HBoV-2108R:50-TCAG
CACTATGAGGAAGG-30, HBoV-Boca2R:50-CCATCAAGATCTGC
GAGTTCAT-30, HBoV-Boca3F:50-ACTCGCAGATCTTGATGGAA
AT-30, HBoV-Boca3R: 50-TGTACAACAACAACACATTAAA-30, and
others were based on the published HBoV putative VP1/VP2
gene sequences (DQ000495).29,30 Viral DNA was amplified by
using a GeneAmp PCR system 9700 (Applied Biosystems,
Foster, CA, USA) and the HotTaq DNA polymerase (QIAGEN)
according to the manufacturer’s recommendations. We used
5 mL of DNA in a volume of 25 mL containing 0.2 mM of each
primer, and the applied thermocycler conditions were as
follows: 94C for 2 minutes for the activation of the DNA
polymerase and denaturing the template, followed by 35
cycles of 94C for 30 seconds, 54C for 30 seconds, and 72C
for 1 minute, followed in turn by an extension of 10 minutes
at 72C. The PCR products were detected on an agarose gel
with a size marker.12
The primer set for complete coding sequences amplifi-
cation was designed based on the HBoV complete coding
sequence available in the GenBank database. All primers
were designed to have closely matching annealing
temperatures so that virtually identical conditions could be
applied for the PCR cycle.Results
Demography
During a 1-year period, there were 705 patients with an age
ranging from 5 months to 9 years whose throat swabs were
obtained from the pediatric clinic. HBoV was found in 35
samples (5%) and it was supposed to be as a single virus in
32 samples because viral isolation of these 32 samples did
not identify other virus. There was one patient who had
positive results of HBoV twice with an interval of half a year
during separate clinical visits.
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Figure 1. Age distribution (A) of HBoV infection and number
of samples and positive percentage of HBoV by age (B). Human
bocavirus most infected children, especially in the group of
patients who were younger than 5 years.
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Figure 2. Monthly distribution (A) and the percentage (B) of
HBoV infection from November 2008 to October 2009. The peak
was between November and March, most in the winter and
spring seasons. HBoV Z human bocavirus.
Table 1 Symptoms of 35 episodes associated with HBoV
infection
Clinical symptoms N (%)
Productive cough 30 (86)
Rhinorrhea 26 (74)
Wheezing 11 (31)
Shortness of breath 4 (11)
Injected eardrum 4 (11)
Fever 23 (66)
Injected throata 27 (77)
Gastrointestinal symptoms 4 (11)
a Throat: there were exudates in two patients and ulcers in
one patient.
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female ratio was 21:13. Twenty-six patients (76%) were
less than 5 years old, and the mean age was 40 months.
The age distribution is shown in Fig. 1. There were two
patients who had underlying diseases, which were partial
anomalous pulmonary venous return status postoperation
and Kawasaki disease history. The seasonal distribution is
demonstrated in Fig. 2A and B, which shows HBoV to be
predominant in the winter and the spring.
Symptoms
Table 1 shows the clinical symptoms among the 35 episodes
of HBoV infections. The common symptoms were produc-
tive cough (86%) followed by rhinorrhea (74%) and throat
injection (7%). Fever occurred in two-thirds of patients with
HBoV infection. One-third of the patients presented with
wheezing breath sounds. Gastrointestinal symptoms such as
vomiting, diarrhea, and decreased appetite appeared in
four patients.
Diagnosis
The diagnoses of 35 episodes with HBoV infections are
shown in Table 2. The most common clinical diagnosis was
bronchitis (34%, 12/35), followed by sinusitis (31%, 11/35),pharyngitis (29%, 10/35), and asthma exacerbation (26%,
9/35). Lower respiratory tract infections including bron-
chitis, bronchiolitis, and pneumonia accounted for about
50% of the diagnoses. The definition of pneumonia in our
study is lower respiratory tract disease characterized by
lung infiltration or patch shown in the chest X-ray and fine
crackles on auscultation.
Coinfection with another virus was observed in three
(8.6%) of the HBoV-positive children. Among these three
patients, one had adenovirus, one had influenza A virus, and
the other one had coxsackie A virus. Another patient had
a positive result of mycoplasma IgM. The individual clinical
Table 2 Clinical diagnosis among 35 episodes of bocavirus
infections
Clinical diagnosis N (%)
Bronchiolitis 2 (6)
Bronchitis 12 (34)
Sinusitis 11 (31)
Pneumonia 3 (9)
Pharyngitis/tonsillitis 10 (29)
Pharyngoconjunctival fever 3 (9)
Herpangina 1 (3)
Gastritis 1 (3)
Acute otitis media 3 (9)
Asthma 9 (26)
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fever, bronchopneumonia, exudative tonsillitis with bron-
chitis, and mycoplasmal pneumonia.
Three of the 34 patients needed to be hospitalized for
further treatment of intravenous fluid supplement and
symptomatic medication. Of these three patients, two had
bronchiolitis and one had herpangina. Among the two
bronchiolitis patients, one had positive result of respiratory
syncytial virus antigen in sputum specimen. The patient
who was diagnosed clinically as herpangina was because of
the finding of the only one ulcer in the throat and the viral
culture didn’t yield enterovirus. The RSV bronchiolitis
patient may not be infected only by HBoV, and the rela-
tionship of these two viruses would need further clarifica-
tion. The mean age of three inpatients was 11 months, the
hospital stay was around 5e7 days, and viral cultures of the
throat swabs were all negative.
Discussion
The report was to evaluate HBoV infection in children’s
clinical practice. In our study, 77% of patients with HBoV
infections were younger than 5 years. Most studies found
that HBoV infection occurred throughout the year with
peak occurrences in the winter and spring.29,31 On the other
hand, there were studies showing that there was no obvious
seasonality for HBoV infections.12 In our cohort, the
seasonal distribution showed that 71% of HBoV infections
were between November and March.
Most patients in our study presented with symptoms of
upper respiratory tract infections including fever, cough,
rhinorrhea, and throat injection. Some reports described
that the patients had to be hospitalized because of bron-
chiolitis,32 asthma exacerbation,26,33 and wheezing.34 One
report found that as many of 18% of children hospitalized
with pneumonia were positive for HBoV.7 Most HBoV reports
were retrospective analyses based on hospital settings, and
up to 6.6% of patients required stays in intensive care units,
and up to 40% required oxygen therapy at some point during
their hospitalization.11,31,35 These reports would poten-
tially exaggerate the true role of HBoV in respiratory
diseases and overestimate the severity of disease. We
recruited patients while they had respiratory symptoms at
our outpatient department, so our results might show more
realistic presentations in pediatric groups. In fact, therewere studies that suggested that HBoV occurred rarely in
asymptomatic children4,19 and supported its role in lower
respiratory tract illness.36
There were only three (8.6%) patients who showed
coinfection phenomenon. It was uncertain whether HBoV
exacerbated other viral illnesses, or whether the other viral
pathogens were causative symptoms. Fifty percentage of
the patients presented with lower respiratory tract
involvement. The frequent occurrence of lower respiratory
tract symptoms, especially wheezing, led to the specula-
tion that HBoV may be a significant cause of asthma exac-
erbation.3,4,7e9,11e13,26,28,37e41 In addition to respiratory
diseases, one study found that 9.1% of children with HBoV
infections had gastroenteritis in Spain, and the another
study in Korea showed that only 0.8% of HBoV patients were
hospitalized for gastroenteritis.15,16,42 There was one study
in France, which screened children with Kawasaki disease
for bocavirus, and 31.2% of the samples were found to
be positive,43 however, further investigation was needed
to find the association. Moreover, prolonged detection of
HBoV in nasopharyngeal aspirates of immunocompetent
children with respiratory tract disease was found
recently.44 HBoV DNA was proved to be slowly cleared
during a period of 4.5 months in a five series of samples in
the same patient. In our study, we also identified one
patient who had two HBoV infection episodes with different
clinical diagnoses, bronchitis and sinusitis, respectively, in
the period of half a year without other concurrent path-
ogen. During the interval between the two different clinical
visits in our hospital, no repetitive respiratory tract infec-
tions were noted. The observations could be explained by
several hypotheses including persistent HBoV infection,
reactivation induced by other infections, or reinfection.
Therefore, more examinations are needed. Serologic testing
to diagnose primary infection, detection of HBoV viremia, or
high viral loads in quantitative PCR may be more useful
predictors of HBoV-associated clinical disease than only
qualitative detection of HBoV DNA in respiratory tract
samples. Beside, simultaneous examination of the other
viruses by PCR may be also needed to exclude coinfection.
There was currently no specific treatment available for
HBoV infection because of the lack of cultivability and
relatively benign clinical course in most patients. Supportive
care played a large role in the management and further
copathogens should be investigated because of some degree
of coinfections appearance.
In conclusion, HBoV is an emerging human parvovirus
that may cause respiratory tract infections in young chil-
dren and it appears more in the winter and spring time in
Taiwan (Fig. 2A and B). Diseases associated with HBoV
range from pharyngitis, sinusitis, acute otitis media to
bronchitis, asthma, and even pneumonia.
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